Petrina

@RnkPetrina

Making drugs and health technologies accessible. Manager, Market Access

Montréal, Québec
Vrijeme pridruživanja: siječanj 2020.

Tweetovi

Blokirali ste korisnika/cu @RnkPetrina

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @RnkPetrina

  1. prije 2 sata
    Poništi
  2. proslijedio/la je Tweet
    3. velj

    Tomorrow, February 4th, is and CADTH is joining the conversation by sharing evidence on drugs and health technology. Every action counts. Who are you and what will you do?

    Poništi
  3. proslijedio/la je Tweet
    3. velj

    How proposed changes to the pricing regime in Canada will impact jobs, investments and most critically, patients in need of life-saving innovative medicines.

    Poništi
  4. proslijedio/la je Tweet
    31. sij

    - Demonstrating bioequivalence (BE) with Certara’s Simcyp MechDermA Model. Read here:

    Poništi
  5. proslijedio/la je Tweet
    30. sij

    Featured Report: We completed a review of the clinical effectiveness, cost-effectiveness, patients’ preferences & experiences, as well as the ethical and implementation implications of the use of for the treatment of .

    Poništi
  6. 30. sij
    Poništi
  7. 30. sij
    Poništi
  8. proslijedio/la je Tweet
    27. sij

    Click here to read this week’s news and updates on the Guidelines consultation process:

    Poništi
  9. proslijedio/la je Tweet
    28. sij

    Don't miss out on our first webinar of 2020! Tomorrow we will present, "Updates to the Simcyp Simulator’s Oral Absorption ADAM and M-ADAM Models." Register now:

    Poništi
  10. proslijedio/la je Tweet
    28. sij

    As competition for increasingly constrained healthcare budgets continues to rise, learn about some of the most common tools and field teams are using to secure market access:

    Poništi
  11. 28. sij

    FDA approved Trijardy XR (empagliflozin/linagliptin/metformin hydrochloride, Boehringer Ingelheim/Eli Lilly) indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus ->

    Poništi
  12. proslijedio/la je Tweet
    27. sij

    Artificial intelligence (AI), the term broadly refers to that resemble processes associated with . Explore More @

    Prikaži ovu nit
    Poništi
  13. proslijedio/la je Tweet
    27. sij

    [2/13 Webinar] We'll discuss how pricing has evolved from the 1990s to today for the rare disease drug market and much more! Register here:

    Poništi
  14. 27. sij

    recommended Baqsimi (glucagon, Eli Lilly) for the treatment of severe hypoglycemia reactions which may occur in the management of insulin-treated patients with diabetes mellitus, when impaired consciousness precludes oral carbohydrate ->

    Poništi
  15. 27. sij

    Interesting study on the need for blinding in clinical trials..

    Poništi
  16. 27. sij
    Poništi
  17. 24. sij
    Poništi
  18. 24. sij
    Poništi
  19. proslijedio/la je Tweet
    23. sij

    Free! A compilation of Certara’s biggest challenges and accomplishments in model-informed drug development, health economics/outcomes research and real world evidence, and regulatory science, strategy, and services. To download the blog book, visit

    Poništi
  20. proslijedio/la je Tweet
    23. sij

    En 2018, les médicaments oncologiques représentaient près du tiers des nouvelles approbations, et un tiers des produits pharmaceutiques émergents. Lisez le nouveau rapport Veille des médicaments mis en marché:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·